C0042071||Urokinase
C0071216||Urokinase Receptor
C0024880||Mast Cells
C0597357||fMLF Receptors
C0024880||Mast cell
C0004827||basophils
C0597357||high affinity receptor
C0020846||IgE
C0020846||FcÉ›RI
C0312740||primary effector cells
C0020517||allergic disorders
C0042071||urokinase
C0042071||uPA
C1622667||plasminogen activation system
C0031845||physiological
C0030660||pathological events
C1622501||cell migration
C0021368||inflammation
C0043240||wound healing
C0302600||angiogenesis
C4255448||metastasis
C0042071||uPA
C2717971||serine protease
C0071216||uPAR
C0119748||high affinity glycosyl-phosphatidyl-inositol (GPI)-anchored
C0597357||receptor
C0071216||uPAR
C0042071||uPA
C0243102||activity
C0699040||cell surface
C3822614||activates intracellular signaling
C0021701||integrins
C0206364||receptor tyrosine kinases
C0872043||G-protein-coupled family
C0597357||fMLF chemotaxis receptors
C0597357||fMLF chemotaxis receptors
C1171362||expression
C0042071||uPA
C0071216||uPAR
C0597357||fMLF chemotaxis receptors
C0086418||human
C0024880||mast cells
C0024880||mast cells
C0004827||basophils
C0024880||mast cells
C0042071||uPA
C0008018||chemotaxis
C0024880||mast cells
C0071216||uPAR
C0071216||DII-DIII-uPAR
C0002518||SRSRY sequence
C0597357||fMLF chemotaxis receptors
C2610454||cell chemotaxis
C0024880||mast cells
C0035696||mRNAs
C0597357||fMLF chemotaxis receptors
C0042071||uPA
C0030956||soluble peptide
C0071216||uPAR84-95
C0002518||SRSRY chemotactic sequence
C0071216||uPAR
C0597357||fMLF chemotaxis receptors
C0024880||mast cells
C0008018||chemotaxis
C0042071||uPA
C0008013||chemoattractant
C0024880||mast cells
C0008018||chemotactic
C0003316||epitope
C0071216||uPAR
C0023688||ligand
C0597357||fMLF chemotaxis receptors
C0078058||VEGF-A
C0036536||secretion
C0086418||human
C0024880||mast cells
C0042071||uPA
C0071216||uPAR84-95
C1148560||stimulation.